Company: MLTX
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001821586-25-000011
Chunk: 12

Company: MoonLake Immunotherapeutics
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 12
---
)

Three Months Ended March 31, (in thousands, except share and per share data)20252024Operating expensesResearch and development$(36,459)$(13,014)General and administrative(11,026)(6,806)Total operating expenses(47,485)(19,820)Operating loss(47,485)(19,820)Interest expense(18)—Other income, net7,0975,915Loss before income tax(40,406)(13,905)Income tax expense(153)(70)Net loss$(40,559)$(13,975)Of which: net loss attributable to controlling interests shareholders(39,944)(13,673)Of which: net loss attributable to noncontrolling interests shareholders(615)(302)Net unrealized gain (loss) on marketable securities and short-term investments(2,756)182Actuarial income on employee benefit plans9581Other comprehensive income (loss)(2,661)263Comprehensive loss$(43,220)$(13,712)Comprehensive loss attributable to controlling interests shareholders(42,564)(13,416)Comprehensive loss attributable to noncontrolling interests(656)(296)Weighted-average number of Class A Ordinary Shares, basic and diluted63,233,78862,637,212Basic and diluted net loss per share attributable to controlling interests shareholders$(0.63)$(0.22) 

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.    

3

MOONLAKE IMMUNOTHERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY(Unaudited)

Class A Ordinary SharesClass C Ordinary SharesAdditional Paid-In CapitalAccumulated DeficitAccumulated Other Comprehensive IncomeTotal Shareholders' Equity Noncontrolling InterestsTotal Equity (in thousands except share data)SharesAmountSharesAmountBalance at January 1, 202460,466,453 $6 2,505,476 $— $609,969 $(116,657)$2,358 $495,676 $17,815 $513,491 Share-based compensation under the ESPP and Equity Incentive Plan— — — — 1,693 — — 1,693 (16)1,677 Conversion of MoonLake Class C Ordinary Shares into Class A Ordinary Shares1,493,356 — (1,493,356)— 10